Sustainable Healing Starts Here

In-Person Scheduling Requirement Update

The annual in-person visit requirement applies only to patients prescribed controlled substances.

Requirement Update

Beginning January 1st, 2026, State and Federal law will require that all patients prescribed Schedule II, III, IV, or V medications (controlled substances) must be seen in person by their provider at least once every 12 months.

This change reflects the end of COVID-era waivers and a return to pre-pandemic regulations for controlled substances.

Most of the medications we prescribe (antidepressants, mood stabilizers, etc.) are not controlled substances and therefore do not require an in-person visit.

What Does This Mean For You?

If you are currently prescribed a controlled medication (Schedule II–V), you must have an in-person visit at least once every 12 months to continue receiving your prescription.

Common examples of controlled substances include:

Benzodiazepines: Valium (diazepam), Xanax (alprazolam), Klonopin (clonazepam)
Stimulants: Ritalin, Concerta, Focalin (methylphenidate derivatives), Adderall, Vyvanse (amphetamine salts), Provigil (modafinil)
Sedatives: Lunesta (eszopiclone), Ambien (zolpidem), Sonata (zaleplon)

What do you need to do?

If you have not had an in-person visit in the past 12 months, please schedule one before January 1st, 2026, to avoid any disruption in your prescriptions.
Patients who have not been seen in person within 12 months will be offered non-controlled medication alternatives until an in-person appointment can be scheduled.

If you have questions or need to schedule an appointment, please contact our office as soon as possible.

Reclaim Your Life Today – Reach Out to Mind Body Optimization

For comprehensive, whole-person healing, reach out to our MBO team today. We’re here to help you recover from depression and reunite with your hope, happiness, and well-being.